Hypertrophic cardiomyopathy and ultra-endurance running - Two incompatible entities?

Journal of Cardiovascular Magnetic Resonance

Volumn 13, Issue 1, 2011, Pages

  Wilson, Mathew G ^a   Chandra, Navin ^b   Papadakis, Michael ^b   O'Hanlon, Rory ^c   Prasad, Sanjay K ^d   Sharma, Sanjay ^b  

^a ASPETAR ORTHOPAEDIC AND SPORTS MEDICINE HOSPITAL   (Qatar)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^d ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

athlete's heart; hypertrophic cardiomyopathy; pre participation screening; sudden cardiac death; Ultra endurance exercise

Indexed keywords

GADOLINIUM; MYOSIN BINDING PROTEIN C; CARRIER PROTEIN; MYOSIN-BINDING PROTEIN C;

ADULT; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CASE REPORT; CAUCASIAN; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; ENDURANCE TRAINING; EXERCISE TEST; FIRST DEGREE ATRIOVENTRICULAR BLOCK; GENE MUTATION; GENETIC SCREENING; HEART MUSCLE FIBROSIS; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; MARATHON RUNNER; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RUNNING; ST SEGMENT DEPRESSION; SYSTOLIC HEART MURMUR; T WAVE INVERSION; TISSUE DOPPLER IMAGING; ASYMPTOMATIC DISEASE; DOPPLER ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ENDURANCE; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; GENETIC PREDISPOSITION; GENETICS; MUTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PHENOTYPE;

ADULT; ASYMPTOMATIC DISEASES; CARDIOMYOPATHY, HYPERTROPHIC, FAMILIAL; CARRIER PROTEINS; DNA MUTATIONAL ANALYSIS; ECHOCARDIOGRAPHY, DOPPLER, COLOR; ELECTROCARDIOGRAPHY; EXERCISE TEST; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MUTATION; PHENOTYPE; PHYSICAL ENDURANCE; RUNNING;

EID: 84857670069     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-13-77     Document Type: Article

References (37)

1. Three-dimensional electroanatomic voltage mapping increases accuracy of diagnosing arrhythmogenic right ventricular cardiomyopathy/dysplasia. Corrado D, Basso C, Leoni L, Tokajuk B, Bauce B, Frigo G, Tarantini G, Napodano M, Turrini P, Ramondo A, Daliento L, Nava A, Buja G, Iliceto S, Thiene G, Circulation 2005 111 23 3042 50 10.1161/CIRCULATIONAHA.104.486977 15939822 (Pubitemid 40847780)
2. Causes of sudden death in competitive athletes. Maron BJ, Epstein SE, Roberts WC, J Am Coll Cardiol 1986 7 1 204 14 10.1016/S0735-1097(86)80283-2 3510233 (Pubitemid 16132479)
3. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, Dubourg O, Kuhl U, Maisch B, McKenna WJ, Monserrat L, Pankuweit S, Rapezzi C, Seferovic P, Tavazzi L, Keren A, Eur Heart J 2008 29 2 270 6 17916581
4. Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. Maron BJ, Shirani J, Poliac LC, Mathenge R, Roberts WC, Mueller FO, Jama 1996 276 3 199 204 10.1001/jama.1996.03540030033028 8667563 (Pubitemid 26235063)
5. Nontraumatic sports death in high school and college athletes. Van Camp SP, Bloor CM, Mueller FO, Cantu RC, Olson HG, Med Sci Sports Exerc 1995 27 5 641 7 7674867
6. Ethnic differences in left ventricular remodeling in highly-trained athletes relevance to differentiating physiologic left ventricular hypertrophy from hypertrophic cardiomyopathy. Basavarajaiah S, Boraita A, Whyte G, Wilson M, Carby L, Shah A, Sharma S, J Am Coll Cardiol 2008 51 23 2256 62 10.1016/j.jacc.2007.12.061 18534273 (Pubitemid 351754996)
7. The upper limit of physiological cardiac hypertrophy in elite male and female athletes: the British experience. Whyte GP, George K, Sharma S, Firoozi S, Stephens N, Senior R, McKenna WJ, Eur J Appl Physiol 2004 92 4-5 592 7 15054661 (Pubitemid 39248375)
8. The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. Pelliccia A, Maron BJ, Spataro A, Proschan MA, Spirito P, N Engl J Med 1991 324 5 295 301 10.1056/NEJM199101313240504 1824720
9. Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols. Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E, J Cardiovasc Magn Reson 2008 10 1 35 10.1186/1532-429X-10-35 18605997
10. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling. Rudolph A, Abdel-Aty H, Bohl S, Boye P, Zagrosek A, Dietz R, Schulz-Menger J, J Am Coll Cardiol 2009 53 3 284 91 10.1016/j.jacc.2008.08.064 19147047
11. Hypertrophic cardiomyopathy compatible with successful completion of the marathon. Maron BJ, Wesley YE, Arce J, Am J Cardiol 1984 53 10 1470 1 10.1016/S0002-9149(84)91437-1 6539058 (Pubitemid 14104793)
12. Clinical significance of abnormal electrocardiographic patterns in trained athletes. Pelliccia A, Maron BJ, Culasso F, Di Paolo FM, Spataro A, Biffi A, Caselli G, Piovano P, Circulation 2000 102 3 278 84 10899089 (Pubitemid 30457576)
13. Outcomes in athletes with marked ECG repolarization abnormalities. Pelliccia A, Di Paolo FM, Quattrini FM, Basso C, Culasso F, Popoli G, De Luca R, Spataro A, Biffi A, Thiene G, Maron BJ, N Engl J Med 2008 358 2 152 61 10.1056/NEJMoa060781 18184960
14. Ethnic differences in physiological cardiac adaptation to intense physical exercise in highly trained female athletes. Rawlins J, Carre F, Kervio G, Papadakis M, Chandra N, Edwards C, Whyte GP, Sharma S, Circulation 2010 121 9 1078 85 10.1161/CIRCULATIONAHA.109.917211 20176985
15. Relation of race to electrocardiographic patterns in elite American football players. Magalski A, Maron BJ, Main ML, McCoy M, Florez A, Reid KJ, Epps HW, Bates J, Browne JE, J Am Coll Cardiol 2008 51 23 2250 5 10.1016/j.jacc.2008.01.065 18534272 (Pubitemid 351754997)
16. Significance of deep T-wave inversions in an asymptomatic athlete with a family history of sudden death. Wilson MG, Chatard JC, Hamilton B, Prasad SK, Carre F, Whyte GP, Chalabi H, Clin J Sport Med 2011 21 2 138 40 10.1097/JSM.0b013e3182042a5b 21358505
17. Prevalence of Electrocardiographic Abnormalities in West-Asian and African Male Athletes. Wilson M, Chatard JC, Carre F, Hamilton B, Whyte G, Sharma S, Chalabi H, Br J Sports Med 2011
18. Left ventricular hypertrophy in athletes. Rawlins J, Bhan A, Sharma S, Eur J Echocardiogr 2009
19. Establishment and performance of a magnetic resonance cardiac function clinic. Bellenger NG, Francis JM, Davies CL, Coats AJ, Pennell DJ, J Cardiovasc Magn Reson 2000 2 1 15 22 10.3109/10976640009148669 11545103 (Pubitemid 30183732)
20. Quantification of right and left ventricular function by cardiovascular magnetic resonance. Bellenger NG, Grothues F, Smith GC, Pennell DJ, Herz 2000 25 4 392 9 10.1007/s000590050031 10948775 (Pubitemid 30470078)
21. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Rickers C, Wilke NM, Jerosch-Herold M, Casey SA, Panse P, Panse N, Weil J, Zenovich AG, Maron BJ, Circulation 2005 112 6 855 61 10.1161/CIRCULATIONAHA.104.507723 16087809 (Pubitemid 41170072)
22. Disparity between unusual left ventricular morphology and clinical presentation and course in hypertrophic cardiomyopathy. Maron BJ, Lindberg J, Haas TS, Kitner C, Lesser JR, Am J Cardiol 2010 105 11 1643 4 10.1016/j.amjcard.2010.01.334 20494677
23. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. McCrohon JA, Moon JC, Prasad SK, McKenna WJ, Lorenz CH, Coats AJ, Pennell DJ, Circulation 2003 108 1 54 9 10.1161/01.CIR.0000078641.19365.4C 12821550 (Pubitemid 36859020)
24. Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography. Moon JC, Fisher NG, McKenna WJ, Pennell DJ, Heart 2004 90 6 645 9 10.1136/hrt.2003.014969 15145868 (Pubitemid 38668538)
25. Association between regional ventricular function and myocardial fibrosis in hypertrophic cardiomyopathy assessed by speckle tracking echocardiography and delayed hyperenhancement magnetic resonance imaging. Popovic ZB, Kwon DH, Mishra M, Buakhamsri A, Greenberg NL, Thamilarasan M, Flamm SD, Thomas JD, Lever HM, Desai MY, J Am Soc Echocardiogr 2008 21 12 1299 305 10.1016/j.echo.2008.09. 011 19041572
26. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH, Spirito P, Ten Cate FJ, Wigle ED, J Am Coll Cardiol 2003 42 9 1687 713 10.1016/S0735-1097(03)00941-0 14607462 (Pubitemid 37383745)
27. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Richard P, Charron P, Carrier L, Ledeuil C, Cheav T, Pichereau C, Benaiche A, Isnard R, Dubourg O, Burban M, Gueffet JP, Millaire A, Desnos M, Schwartz K, Hainque B, Komajda M, Circulation 2003 107 17 2227 32 10.1161/01.CIR.0000066323.15244.54 12707239 (Pubitemid 36547217)
28. Diverse patterns of myocardial fibrosis in lifelong, veteran endurance athletes. Wilson M, O'Hanlon R, Prasad S, Deighan A, Macmillan P, Oxborough D, Godfrey R, Smith G, Maceira A, Sharma S, George K, Whyte G, J Appl Physiol 2011 110 6 1622 6 10.1152/japplphysiol.01280.2010 21330616
29. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, Thiene G, Jama 2006 296 13 1593 601 10.1001/jama.296.13.1593 17018804 (Pubitemid 44515020)
30. Task Force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and Marfan syndrome. Maron BJ, Ackerman MJ, Nishimura RA, Pyeritz RE, Towbin JA, Udelson JE, J Am Coll Cardiol 2005 45 8 1340 5 10.1016/j.jacc.2005.02.011 15837284 (Pubitemid 40523165)
31. Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Pelliccia A, Fagard R, Bjornstad HH, Anastassakis A, Arbustini E, Assanelli D, Biffi A, Borjesson M, Carre F, Corrado D, Delise P, Dorwarth U, Hirth A, Heidbuchel H, Hoffmann E, Mellwig KP, Panhuyzen-Goedkoop N, Pisani A, Solberg EE, van-Buuren F, Vanhees L, Blomstrom-Lundqvist C, Deligiannis A, Dugmore D, Glikson M, Hoff PI, Hoffmann A, Hoffmann E, Horstkotte D, Nordrehaug JE, Oudhof J, McKenna WJ, Penco M, Priori S, Reybrouck T, Senden J, Spataro A, Thiene G, Eur Heart J 2005 26 14 1422 45 10.1093/eurheartj/ehi325 15923204 (Pubitemid 41378990)
32. Recommendations for participation in leisure-time physical activity and competitive sports of patients with arrhythmias and potentially arrhythmogenic conditions. Part II: ventricular arrhythmias, channelopathies and implantable defibrillators. Heidbuchel H, Corrado D, Biffi A, Hoffmann E, Panhuyzen-Goedkoop N, Hoogsteen J, Delise P, Hoff PI, Pelliccia A, Eur J Cardiovasc Prev Rehabil 2006 13 5 676 86 10.1097/01.hjr.0000239465.26132.29 17001205 (Pubitemid 44462668)
33. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. Moon JC, McKenna WJ, McCrohon JA, Elliott PM, Smith GC, Pennell DJ, J Am Coll Cardiol 2003 41 9 1561 7 10.1016/S0735-1097(03)00189-X 12742298 (Pubitemid 36543376)
34. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. O'Hanlon R, Grasso A, Roughton M, Moon JC, Clark S, Wage R, Webb J, Kulkarni M, Dawson D, Sulaibeekh L, Chandrasekaran B, Bucciarelli-Ducci C, Pasquale F, Cowie MR, McKenna WJ, Sheppard MN, Elliott PM, Pennell DJ, Prasad SK, J Am Coll Cardiol 2010 56 11 867 74 10.1016/j.jacc.2010.05.010 20688032
35. Activation delay after premature stimulation in chronically diseased human myocardium relates to the architecture of interstitial fibrosis. Kawara T, Derksen R, de Groot JR, Coronel R, Tasseron S, Linnenbank AC, Hauer RN, Kirkels H, Janse MJ, de Bakker JM, Circulation 2001 104 25 3069 75 10.1161/hc5001. 100833 11748102 (Pubitemid 34014059)
36. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy. Rubinshtein R, Glockner JF, Ommen SR, Araoz PA, Ackerman MJ, Sorajja P, Bos JM, Tajik AJ, Valeti US, Nishimura RA, Gersh BJ, Circ Heart Fail 2010 3 1 51 8 10.1161/CIRCHEARTFAILURE.109.854026 19850699
37. Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy. Maron BJ, Circulation 2010 121 3 445 56 10.1161/CIRCULATIONAHA.109.878579 20100987